Proposed legislation would regulate use of antipsychotics in nursing home residents
By
McKnight's Staff
May 23, 2012
A proposed bill would require nursing home staff to obtain informed consent from a resident or their legally designated representative acknowledging the potential risks and side effects associated with...
Study: Focusing on neurology — not just psychiatry — helps cut antipsychotic use in SNF residents
By
Kristen Fischer
Sep 29, 2023
A neurology-focused effort to reduce antipsychotic drugs in skilled nursing facilities lowered usage by 68% in people with behavioral and psychological symptoms of dementia, according to a new report published...
Government agency calls off effort to assess antipsychotic use in nursing homes, watchdog group reports
By
Tim Mullaney
Jul 26, 2013
A government investigation into nursing homes’ antipsychotic prescribing practices will not move forward due to budget and staff cuts, according to nonprofit investigative news organization The Center...
With scope unknown, nursing homes brace for new schizophrenia audits
By
Kimberly Marselas
Feb 10, 2023
Three weeks after federal officials announced they would begin auditing nursing homes for overuse of schizophrenia diagnoses, providers are still looking for answers about what those investigations will...
Nursing home antipsychotic use has dipped nearly 19% under national effort, latest figures show
By
Tim Mullaney
Oct 31, 2014
The percent of long-stay nursing home residents receiving antipsychotic medication has decreased 18.8% under a nationwide initiative that started in 2012.
Disadvantages, understaffing combine to ratchet up nursing homes’ antipsychotic reliance: study
By
Josh Henreckson
Apr 25, 2024
Nursing homes in disadvantaged neighborhoods are more likely to rely on antipsychotics, especially when understaffed, compared to those in more affluent areas, according to a new study in Jama Network...
CMS must refine data on antipsychotic drug use in nursing homes, OIG says
By
Alicia Lasek
May 07, 2021
The Minimum Data Set should not be CMS’ sole source for determining the number of nursing home residents using antipsychotic drugs, according to a new report from HHS’ Office of the Inspector General.
Prescribing patterns in nursing homes may impact that of assisted living neighbors, study finds
By
Alicia Lasek
Sep 14, 2021
Antipsychotic and anti-anxiety prescribing in nursing homes may have an effect on prescribing in local and affiliated assisted living communities, investigators have found.
Providers respond to report of inadequate government oversight of antipsychotics prescriptions
By
McKnight's Staff
May 14, 2013
Long-term care organizations have responded to a report that physicians are prescribing antipsychotic medications for seniors without proper oversight from the Centers for Medicare & Medicaid Services....
Audits trigger new concern over aging CMS antipsychotic standards
By
Kimberly Marselas
May 03, 2023
Worries over federal audits designed to monitor nursing homes for inappropriate schizophrenia diagnosing continued to mount as some providers learned they had “failed” their check-ups months into the...